Literature DB >> 32840141

Latest Advancements in Artificial Intelligence-Enabled Technologies in Treating Type 1 Diabetes.

Feng Qian1, Patrick J Schumacher1.   

Abstract

Entities:  

Keywords:  artificial intelligence; continuous glucose monitors

Year:  2020        PMID： 32840141      PMCID： PMC7782992          DOI： 10.1177/1932296820949940

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  13 in total

1.  Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

Authors:  Sue A Brown; Boris P Kovatchev; Dan Raghinaru; John W Lum; Bruce A Buckingham; Yogish C Kudva; Lori M Laffel; Carol J Levy; Jordan E Pinsker; R Paul Wadwa; Eyal Dassau; Francis J Doyle; Stacey M Anderson; Mei Mei Church; Vikash Dadlani; Laya Ekhlaspour; Gregory P Forlenza; Elvira Isganaitis; David W Lam; Craig Kollman; Roy W Beck
Journal:  N Engl J Med       Date:  2019-10-16       Impact factor: 91.245

Review 2.  A Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control.

Authors:  Boris Kovatchev
Journal:  Trends Endocrinol Metab       Date:  2019-05-28       Impact factor: 12.015

3.  Comparative Accuracy Analysis of a Real-time and an Intermittent-Scanning Continuous Glucose Monitoring System.

Authors:  Manuela Link; Ulrike Kamecke; Delia Waldenmaier; Stefan Pleus; Arturo Garcia; Cornelia Haug; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2019-12-17

4.  Prediction and prevention of hypoglycaemic events in type-1 diabetic patients using machine learning.

Authors:  Josep Vehí; Iván Contreras; Silvia Oviedo; Lyvia Biagi; Arthur Bertachi
Journal:  Health Informatics J       Date:  2019-06-13       Impact factor: 2.681

5.  Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control Inputs.

Authors:  Navid Resalat; Wade Hilts; Joseph El Youssef; Nichole Tyler; Jessica R Castle; Peter G Jacobs
Journal:  J Diabetes Sci Technol       Date:  2019-10-09

6.  Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.

Authors:  Johan Jendle; Johannes Pöhlmann; Simona de Portu; Jayne Smith-Palmer; Stéphane Roze
Journal:  Diabetes Technol Ther       Date:  2019-02-20       Impact factor: 6.118

7.  Predicting and Preventing Nocturnal Hypoglycemia in Type 1 Diabetes Using Big Data Analytics and Decision Theoretic Analysis.

Authors:  Clara Mosquera-Lopez; Robert Dodier; Nichole S Tyler; Leah M Wilson; Joseph El Youssef; Jessica R Castle; Peter G Jacobs
Journal:  Diabetes Technol Ther       Date:  2020-05-14       Impact factor: 6.118

8.  Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.

Authors:  Gregory P Forlenza; Orit Pinhas-Hamiel; David R Liljenquist; Dorothy I Shulman; Timothy S Bailey; Bruce W Bode; Michael A Wood; Bruce A Buckingham; Kevin B Kaiserman; John Shin; Suiying Huang; Scott W Lee; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2018-12-26       Impact factor: 6.118

9.  Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study.

Authors:  Mary A M Rogers; Catherine Kim; Tanima Banerjee; Joyce M Lee
Journal:  BMC Med       Date:  2017-11-08       Impact factor: 8.775

10.  Utility of Big Data in Predicting Short-Term Blood Glucose Levels in Type 1 Diabetes Mellitus Through Machine Learning Techniques.

Authors:  Ignacio Rodríguez-Rodríguez; Ioannis Chatzigiannakis; José-Víctor Rodríguez; Marianna Maranghi; Michele Gentili; Miguel-Ángel Zamora-Izquierdo
Journal:  Sensors (Basel)       Date:  2019-10-16       Impact factor: 3.576
View more
  1 in total

1.  Analysis of the Application Effect of Exercise Rehabilitation Therapy Based on Data Mining in the Prevention and Treatment of Knee Osteoarthritis.

Authors:  Wei Liu; Congan Wang; Gongchang Yu; Bin Shi; Jingwen Wang
Journal:  Comput Math Methods Med       Date:  2022-09-05       Impact factor: 2.809
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.